Sultan River Holdings (SRH) also provides capital to certain healthcare investment opportunities. Typically, the mandate is inception through Series A funding. We actively participate in the organization, GTM (Go To Market) and early expansion sales and operations. Specialization investments have been made in medical real estate, innovation, healthcare IS solutions, radiology, OTC pharmaceutical, biotechnology and healthcare services. SRH stays active in participation while attracting growth capital and talent to help achieve its potential.

Our investment territories include North America, SE Asia and North Asia. More specifically, we have interest in aesthetics in Asia, including mainland China, as well as eldercare, healthcare accessibility via mobile technology, patient treatment delivery strategies and home infusion services.